Gerresheimer AG (GRRMF)
OTC PINK OTC PINK Primary 
Gerresheimer appoints Uwe Röhrhoff as new interim CEO
Medical equipment maker Gerresheimer said on Tuesday it had appointed Uwe Röhrhoff as interim CEO, effective November 1, 2025. He succeeds Dietmar Siemssen, who will step down as CEO by mutual agreement with the company's supervisory board on October 31.
Gerresheimer finds 2024 revenue-recognition issues after external probe
Medical equipment maker Gerresheimer said it has obtained the initial findings from an investigation by an external law firm into the recognition of revenue and profit from bill-and-hold agreements in the 2024 financial year.
Gerresheimer AG (GRRMY) Q3 2025 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMY) Q3 2025 Earnings Call October 9, 2025 2:30 AM EDT Company Participants Guido Pickert - Head of Investor Relations Dietmar Siemssen - CEO, Chairman of the Management Board and CEO of Plastics, Devices & Advanced Technologies Division Wolf Lehmann - CFO & Member of the Management Board Conference Call Participants Edward Hall - Stifel, Nicolaus & Company, Incorporated, Research Division Olivier Calvet - UBS Investment Bank, Research Division David Adlington - JPMorgan Chase & Co, Research Division Anna Snopkowski - KeyBanc Capital Markets Inc., Research Division Presentation Guido Pickert Head of Investor Relations Good morning, everyone, and welcome to our presentation of our preliminary Q3 2025 results. With us today are our CEO, Dietmar Siemssen; and our new CFO, Wolf Lehmann, who will lead you through our Q3 development and the financials.
Gerresheimer's shares fall 11% after another outlook cut
Shares in Gerresheimer fell 11% on Thursday, a day after the German packaging and medical equipment maker cut its 2025 guidance for the third time this year.
Activist investor wants review at Gerresheimer after taking stake
Active Ownership, a major shareholder in Gerresheimer , said on Thursday it saw major potential for value creation at the German packaging and medical equipment specialist and called for a strategic review, a second activist investor to do so.
Gerresheimer cuts guidance for 2025 citing weak demand
German packaging and medical equipment maker Gerresheimer cut its guidance for 2025 on Monday, citing continued weak demand in the cosmetics sector and a decline in demand for containment solutions for liquid medications.
Gerresheimer: Strong Growth Projections Make Stock Look Cheap
Gerresheimer's strategic shift to value-driven solutions in pharma packaging supports higher margins and justifies a premium valuation over traditional packaging peers. Despite a weak Q1 with net loss and negative cash flow, management guides for strong revenue and margin recovery, projecting 22% EBITDA margin for FY 2025. Long-term outlook is robust: Management expects 8-10% annual revenue growth, EBITDA margin expansion, and double-digit EPS growth as Bormioli integration delivers synergies.
Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMF) Q1 2025 Earnings Conference Call April 11, 2025 4:00 AM ET Company Participants Guido Pickert - Vice President, Corporate Investor Relations Dietmar Siemssen - Chief Executive Officer Bernd Metzner - Chief Financial Officer Conference Call Participants James Vane-Tempest - Jefferies Victoria Lambert - Berenberg David Adlington - JPMorgan Odysseas Manesiotis - BNP Paribas Olivier Calvet - UBS Edward Hall - Stifel Delphine Le Louet - Bernstein Alexander Galitsa - HAIB Operator Ladies and gentlemen, welcome to the publication Q1 2025 Results Conference Call. I am George, the Chorus Call operator.
Gerresheimer's first-quarter results hit by low demand in moulded glass
German packaging and medical equipment maker Gerresheimer reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe revenues into later quarters.
Gerresheimer AG (GRRMF) Q4 2024 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMF) Q4 2024 Results Conference Call February 26, 2025 4:00 AM ET Company Participants Guido Pickert - Investor Relations Dietmar Siemssen - Chief Executive Officer Bernd Metzner - Chief Financial Officer & Member of the Management Board Conference Call Participants Oliver Reinberg - Kepler Cheuvreux Paul Knight - KeyBanc Oliver Metzger - ODDO James Vane-Tempest - Jefferies Victoria Lambert - Berenberg Falko Friedrichs - Deutsche Bank Olivier Calvet - UBS David Adlington - JPMorgan Edward Hall - Stifel Delphine Le Louet - Bernstein Alexander Galitsa - Hauck Aufhauser Investment Banking Operator Ladies and gentlemen, welcome to the publication of Q4 and Full Year 2024 Results Conference Call. I'm Vicki, the Chorus Call operator.
Gerresheimer slashes revenue guidance for 2025 in half
German packaging and medical equipment maker Gerresheimer halved its guidance for 2025 on Wednesday.
Gerresheimer draws interest from Phillips-Medisize and Bain, Bloomberg News reports
German medical packaging maker Gerresheimer has garnered interest from US medical solutions company Phillips-Medisize and buyout firm Bain Capital for parts or all of Gerresheimer, Bloomberg News reported on Wednesday, citing sources.
